ZA200707006B - Conjugates of biologically active proteins having a modified in vivo half-life - Google Patents

Conjugates of biologically active proteins having a modified in vivo half-life

Info

Publication number
ZA200707006B
ZA200707006B ZA200707006A ZA200707006A ZA200707006B ZA 200707006 B ZA200707006 B ZA 200707006B ZA 200707006 A ZA200707006 A ZA 200707006A ZA 200707006 A ZA200707006 A ZA 200707006A ZA 200707006 B ZA200707006 B ZA 200707006B
Authority
ZA
South Africa
Prior art keywords
conjugates
life
modified
biologically active
vivo half
Prior art date
Application number
ZA200707006A
Inventor
Besman Marc
Chipman Stewart
Leung David
Singer Jack
Original Assignee
Cell Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Therapeutics Inc filed Critical Cell Therapeutics Inc
Publication of ZA200707006B publication Critical patent/ZA200707006B/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
ZA200707006A 2005-01-25 2006-01-25 Conjugates of biologically active proteins having a modified in vivo half-life ZA200707006B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64711905P 2005-01-25 2005-01-25

Publications (1)

Publication Number Publication Date
ZA200707006B true ZA200707006B (en) 2008-11-26

Family

ID=39043043

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200707006A ZA200707006B (en) 2005-01-25 2006-01-25 Conjugates of biologically active proteins having a modified in vivo half-life

Country Status (2)

Country Link
CN (1) CN101111516B (en)
ZA (1) ZA200707006B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1841787A2 (en) * 2005-01-25 2007-10-10 Cell Therapeutics, Inc. Conjugates of biologically active proteins having a modified in vivo half-life
CN102264757B (en) * 2008-12-29 2014-05-21 隆萨布莱纳公司 Process for production of bivalirudin
CN107743494B (en) * 2015-06-02 2022-04-29 诺和诺德股份有限公司 Insulin with polar recombinant extensions
CN108680634B (en) * 2018-08-28 2023-09-08 长沙理工大学 L-cystine detection method and sensor based on glutathione modified gate gold electrode
WO2023160499A1 (en) * 2022-02-23 2023-08-31 盛元医药广州有限公司 Peptide, ophthalmic pharmaceutical composition containing same and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1405183A (en) * 2001-08-10 2003-03-26 中国人民解放军军事医学科学院生物工程研究所 Serum albumin and granulocyte-macrophage colony stimulating factor fusion protein

Also Published As

Publication number Publication date
CN101111516A (en) 2008-01-23
CN101111516B (en) 2013-02-27

Similar Documents

Publication Publication Date Title
IL184763A0 (en) Conjugates of biologically active proteins having a modified in vivo half-life
EP2089052A4 (en) Peg linker compounds and biologically active conjugates thereof
HRP20130720T1 (en) Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
IL184565A0 (en) Conjugates of a polypeptide and an oligosaccharide
PL1877073T3 (en) Non-cytotoxic protein conjugates
IL192104A0 (en) Stable protein formulations
LT1912671T (en) Beta-glucuronide-linker drug conjugates
EP1781689A4 (en) Conjugates and therapeutic uses thereof
IL179077A0 (en) Chemical linkers and conjugates thereof
IL180762A (en) Insulin-oligomer conjugates and formulations and uses thereof
EG26619A (en) Four branched dendrimer-peg for conjugation to proteins and peptides
IL200113A0 (en) Chemical linkers with single amino acids and conjugates thereof
IL187503A0 (en) Stable and soluble antibodies
IL185103A0 (en) Cat allergen conjugates and uses thereof
EP2111237A4 (en) Fibrin-binding peptides and conjugates thereof
EP1981547A4 (en) Stable therapeutic formulations
IL178687A0 (en) Medical uses of carrier conjugates of non-human tnf-peptides
IL184423A0 (en) Homogeneous preparations of il-31
EP1945791A4 (en) Expression of soluble factor viii proteins in bacteria
EP1934349A4 (en) Bacterial delivery of biologically active polypeptides
EP1620120A4 (en) Long acting biologically active conjugates
EP1718335A4 (en) Drug conjugates
EP1948676A4 (en) Bioactive substance-blood protein conjugate and stabilization of a bioactive substance using the same
ZA200707006B (en) Conjugates of biologically active proteins having a modified in vivo half-life
GB2411404B (en) Biologically active peptide conjugates